Related Experiment Video
Updated: Mar 22, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Empiric intravenous fluid and electrolyte therapy in patients with Ebola virus disease
1Liverpool School of Tropical Medicine, Liverpool, UK luke.hunt@doctors.org.uk.
Abstract:
The role of intravenous fluid and electrolyte replacement is increasingly recognised in the clinical management of Ebola virus disease. However, outbreaks typically occur in resource-limited settings where electrolyte measurement may be initially unavailable. Here we highlight potential strategies for empiric fluid and electrolyte therapy based on experience from Sierra Leone.
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Kidney Injury IV: Diagnostic Studies and Prevention

